The joint approach facilitates a smooth transition between drug substance and product stages, optimising timelines.

NoviThera ApS (“NoviThera”), a majority owned subsidiary of Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic ...

PolyPeptide Group AG (VTX:PPGN) shareholders should be happy to see the share price up 23% in the last month. But that doesn't change the fact that the returns over the last year have been ...

Baar, July 13 th, 2023 – PolyPeptide Group AG (SIX: PPGN) achieves H1 2023 revenue of around EUR 132 million driven by strong momentum in its peptide business. It expects 2023 to be a transitional ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization ...

Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all proposals put ...

There is new research into a new battery technology platform that is completely metal-free. This new battery technology platform utilizes a polypeptide organic radical construction. Almost all Li-ion ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Cord blood appetite hormone levels are associated with early-life growth trajectories and childhood adiposity.

Planta, Vol. 218, No. 6 (April 2004), pp. 1008-1018 (11 pages) Calcium ions play a key role in the elongation and orientation of pollen tubes. We found that significant amounts of 21-kDa polypeptide ...